相关实验视频

Updated: May 25, 2025

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

与erlotinib相关的皮疹通过使用全身静脉免疫球蛋白和干细胞的新疗法得到解决

Iya A Agha¹, Erika Malana², Stanley Skopit²

¹Dermatology, New York Institute of Technology College of Osteopathic Medicine, New York, USA.

|February 27, 2025

概括

肺癌患者因EGFR抑制剂引起的严重皮疹可以得到有效治疗. 静脉注射免疫球蛋白 (IVIG) 和干细胞解决了耐火性皮疹,允许继续癌症治疗.

科学领域:

在瘤学瘤学.
皮肤病学皮肤病学
药理学药理学是指药理学的学科.

背景情况:

表皮生长因子受体 (EGFR) 抑制剂在治疗非小细胞肺癌 (NSCLC) 中至关重要.
药物诱导的皮肤反应,包括乳头皮疹,是EGFR抑制剂的常见副作用.
耐药病例显著影响患者的生活质量和治疗坚持.

研究的目的:

报告第一个经过记录的耐火EGFR抑制剂诱导皮疹病例,该病例已成功用静脉注射免疫球蛋白 (IVIG) 和干细胞治疗.
突出一种新的治疗方法,用于管理针对性癌症治疗的严重皮肤不良反应.

主要方法:

一个67岁的男性EGFR阳性NSCLC接受erlotinib的案例研究.
记录了严重的乳头皮质皮疹,对局部类固醇和口服抗生素没有反应.
使用静脉注射免疫球蛋白 (IVIG) 和干细胞的组合治疗.

主要成果:

在IVIG和干细胞治疗后,药物爆发的完全解决.
埃洛尼布治疗的成功延续,皮疹没有复发.
显著改善患者的生活质量.

结论:

静脉注射免疫球蛋白 (IVIG) 与干细胞结合,代表了耐火EGFR抑制剂诱导的皮肤皮疹的有前途的治疗方法.
这种治疗策略可以使患者能够继续进行必要的癌症治疗.
需要进一步的研究来探索这种综合方法在管理药物诱导的皮肤毒性的有效性和机制.

关键词:

药物皮疹药物皮疹药物反应药物反应药物反应治疗药物反应治疗与EGFR抑制剂相关的皮疹埃尔洛丁尼布 (erlotinib) 是一种药物.静脉注射免疫球蛋白 (IVIG) 的使用

更多相关视频

Discrimination and Characterization of Heterocellular Populations Using Quantitative Imaging Techniques

Discrimination and Characterization of Heterocellular Populations Using Quantitative Imaging Techniques

Published on: June 30, 2017

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...